Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system. It combines neuroplasticity-driven training with impairment-targeted therapies and assistive technologies across acute, inpatient, outpatient, community, and home settings, typically addressing motor control, gait and balance, upper-limb function, spasticity, swallowing and speech, cognition, and activities of daily living, with outcomes tracked using standardized functional measures and safety constraints specific to neurological populations.
The global Neurorehabilitation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Asia-Pacific market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Neurorehabilitation include Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma AG, Neuronetics, Wuhan Yiruide Group, Magstim and Nanjing Vishee Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Neurorehabilitation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Neurorehabilitation, also provides the revenue of main regions and countries. Of the upcoming market potential for Neurorehabilitation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurorehabilitation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurorehabilitation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neurorehabilitation revenue, projected growth trends, production technology, application and end-user industry.
Neurorehabilitation Segment by Company
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma AG
Neuronetics
Wuhan Yiruide Group
Magstim
Nanjing Vishee Medical
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical
LivaNova
Neurorehabilitation Segment by Type
Implantable Neurorehabilitation Systems
Neurorobotic Systems
Functional Electrical Stimulation and Neuroprosthetics
Brain-computer Interfaces
Non-invasive Stimulators
Sensor-based Assessment and Digital Rehab Platforms
Other
Neurorehabilitation Segment by Application
Hospitals
Clinics
Neurorehabilitation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Neurorehabilitation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Neurorehabilitation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurorehabilitation revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
- Market Overview
- Product Definition
- Neurorehabilitation Market by Type
- Global Neurorehabilitation Market Size by Type, 2021 VS 2025 VS 2032
- Implantable Neurorehabilitation Systems
- Neurorobotic Systems
- Functional Electrical Stimulation and Neuroprosthetics
- Brain-computer Interfaces
- Non-invasive Stimulators
- Sensor-based Assessment and Digital Rehab Platforms
- Other
- Neurorehabilitation Market by Application
- Global Neurorehabilitation Market Size by Application, 2021 VS 2025 VS 2032
- Hospitals
- Clinics
- Assumptions and Limitations
- Study Goals and Objectives
- Neurorehabilitation Market Dynamics
- Neurorehabilitation Industry Trends
- Neurorehabilitation Industry Drivers
- Neurorehabilitation Industry Opportunities and Challenges
- Neurorehabilitation Industry Restraints
- Global Growth Perspective
- Global Neurorehabilitation Market Perspective (2021-2032)
- Global Neurorehabilitation Growth Trends by Region
- Global Neurorehabilitation Market Size by Region: 2021 VS 2025 VS 2032
- Global Neurorehabilitation Market Size by Region (2021-2026)
- Global Neurorehabilitation Market Size by Region (2027-2032)
- Competitive Landscape by Players
- Global Neurorehabilitation Revenue by Players
- Global Neurorehabilitation Revenue by Players (2021-2026)
- Global Neurorehabilitation Revenue Market Share by Players (2021-2026)
- Global Neurorehabilitation Players Revenue Share Top 10 and Top 5 in 2025
- Global Neurorehabilitation Key Players Ranking, 2024 VS 2025 VS 2026
- Global Neurorehabilitation Key Players Headquarters & Area Served
- Global Neurorehabilitation Players, Product Type & Application
- Global Neurorehabilitation Players Establishment Date
- Market Competitive Analysis
- Global Neurorehabilitation Market CR5 and HHI
- 2025 Neurorehabilitation Tier 1, Tier 2, and Tier 3
- Global Neurorehabilitation Revenue by Players
- Neurorehabilitation Market Size by Type
- Global Neurorehabilitation Revenue by Type (2021 VS 2025 VS 2032)
- Global Neurorehabilitation Revenue by Type (2021-2032)
- Global Neurorehabilitation Revenue Market Share by Type (2021-2032)
- Neurorehabilitation Market Size by Application
- Global Neurorehabilitation Revenue by Application (2021 VS 2025 VS 2032)
- Global Neurorehabilitation Revenue by Application (2021-2032)
- Global Neurorehabilitation Revenue Market Share by Application (2021-2032)
- Company Profiles
- Medtronic
- Medtronic Company Information
- Medtronic Business Overview
- Medtronic Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Medtronic Neurorehabilitation Product Portfolio
- Medtronic Recent Developments
- Abbott Laboratories
- Abbott Laboratories Company Information
- Abbott Laboratories Business Overview
- Abbott Laboratories Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Abbott Laboratories Neurorehabilitation Product Portfolio
- Abbott Laboratories Recent Developments
- Boston Scientific
- Boston Scientific Company Information
- Boston Scientific Business Overview
- Boston Scientific Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Boston Scientific Neurorehabilitation Product Portfolio
- Boston Scientific Recent Developments
- Bioness
- Bioness Company Information
- Bioness Business Overview
- Bioness Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Bioness Neurorehabilitation Product Portfolio
- Bioness Recent Developments
- Hocoma AG
- Hocoma AG Company Information
- Hocoma AG Business Overview
- Hocoma AG Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Hocoma AG Neurorehabilitation Product Portfolio
- Hocoma AG Recent Developments
- Neuronetics
- Neuronetics Company Information
- Neuronetics Business Overview
- Neuronetics Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Neuronetics Neurorehabilitation Product Portfolio
- Neuronetics Recent Developments
- Wuhan Yiruide Group
- Wuhan Yiruide Group Company Information
- Wuhan Yiruide Group Business Overview
- Wuhan Yiruide Group Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Wuhan Yiruide Group Neurorehabilitation Product Portfolio
- Wuhan Yiruide Group Recent Developments
- Magstim
- Magstim Company Information
- Magstim Business Overview
- Magstim Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Magstim Neurorehabilitation Product Portfolio
- Magstim Recent Developments
- Nanjing Vishee Medical
- Nanjing Vishee Medical Company Information
- Nanjing Vishee Medical Business Overview
- Nanjing Vishee Medical Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Nanjing Vishee Medical Neurorehabilitation Product Portfolio
- Nanjing Vishee Medical Recent Developments
- Ekso Bionics
- Ekso Bionics Company Information
- Ekso Bionics Business Overview
- Ekso Bionics Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Ekso Bionics Neurorehabilitation Product Portfolio
- Ekso Bionics Recent Developments
- Alter G
- Alter G Company Information
- Alter G Business Overview
- Alter G Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Alter G Neurorehabilitation Product Portfolio
- Alter G Recent Developments
- MagVenture
- MagVenture Company Information
- MagVenture Business Overview
- MagVenture Neurorehabilitation Revenue and Gross Margin (2021-2026)
- MagVenture Neurorehabilitation Product Portfolio
- MagVenture Recent Developments
- Tyromotion
- Tyromotion Company Information
- Tyromotion Business Overview
- Tyromotion Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Tyromotion Neurorehabilitation Product Portfolio
- Tyromotion Recent Developments
- Soterix Medical
- Soterix Medical Company Information
- Soterix Medical Business Overview
- Soterix Medical Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Soterix Medical Neurorehabilitation Product Portfolio
- Soterix Medical Recent Developments
- Neuroelectrics
- Neuroelectrics Company Information
- Neuroelectrics Business Overview
- Neuroelectrics Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Neuroelectrics Neurorehabilitation Product Portfolio
- Neuroelectrics Recent Developments
- Bionik Laboratories
- Bionik Laboratories Company Information
- Bionik Laboratories Business Overview
- Bionik Laboratories Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Bionik Laboratories Neurorehabilitation Product Portfolio
- Bionik Laboratories Recent Developments
- Helius Medical
- Helius Medical Company Information
- Helius Medical Business Overview
- Helius Medical Neurorehabilitation Revenue and Gross Margin (2021-2026)
- Helius Medical Neurorehabilitation Product Portfolio
- Helius Medical Recent Developments
- LivaNova
- LivaNova Company Information
- LivaNova Business Overview
- LivaNova Neurorehabilitation Revenue and Gross Margin (2021-2026)
- LivaNova Neurorehabilitation Product Portfolio
- LivaNova Recent Developments
- Medtronic
- North America
- North America Neurorehabilitation Revenue (2021-2032)
- North America Neurorehabilitation Revenue by Type (2021-2032)
- North America Neurorehabilitation Revenue by Type (2021-2026)
- North America Neurorehabilitation Revenue by Type (2027-2032)
- North America Neurorehabilitation Revenue Share by Type (2021-2032)
- North America Neurorehabilitation Revenue by Application (2021-2032)
- North America Neurorehabilitation Revenue by Application (2021-2026)
- North America Neurorehabilitation Revenue by Application (2027-2032)
- North America Neurorehabilitation Revenue Share by Application (2021-2032)
- North America Neurorehabilitation Revenue by Country
- North America Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
- North America Neurorehabilitation Revenue by Country (2021-2026)
- North America Neurorehabilitation Revenue by Country (2027-2032)
- United States
- Canada
- Mexico
- Europe
- Europe Neurorehabilitation Revenue (2021-2032)
- Europe Neurorehabilitation Revenue by Type (2021-2032)
- Europe Neurorehabilitation Revenue by Type (2021-2026)
- Europe Neurorehabilitation Revenue by Type (2027-2032)
- Europe Neurorehabilitation Revenue Share by Type (2021-2032)
- Europe Neurorehabilitation Revenue by Application (2021-2032)
- Europe Neurorehabilitation Revenue by Application (2021-2026)
- Europe Neurorehabilitation Revenue by Application (2027-2032)
- Europe Neurorehabilitation Revenue Share by Application (2021-2032)
- Europe Neurorehabilitation Revenue by Country
- Europe Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
- Europe Neurorehabilitation Revenue by Country (2021-2026)
- Europe Neurorehabilitation Revenue by Country (2027-2032)
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- China
- China Neurorehabilitation Revenue (2021-2032)
- China Neurorehabilitation Revenue by Type (2021-2032)
- China Neurorehabilitation Revenue by Type (2021-2026)
- China Neurorehabilitation Revenue by Type (2027-2032)
- China Neurorehabilitation Revenue Share by Type (2021-2032)
- China Neurorehabilitation Revenue by Application (2021-2032)
- China Neurorehabilitation Revenue by Application (2021-2026)
- China Neurorehabilitation Revenue by Application (2027-2032)
- China Neurorehabilitation Revenue Share by Application (2021-2032)
- Asia (Excluding China)
- Asia Neurorehabilitation Revenue (2021-2032)
- Asia Neurorehabilitation Revenue by Type (2021-2032)
- Asia Neurorehabilitation Revenue by Type (2021-2026)
- Asia Neurorehabilitation Revenue by Type (2027-2032)
- Asia Neurorehabilitation Revenue Share by Type (2021-2032)
- Asia Neurorehabilitation Revenue by Application (2021-2032)
- Asia Neurorehabilitation Revenue by Application (2021-2026)
- Asia Neurorehabilitation Revenue by Application (2027-2032)
- Asia Neurorehabilitation Revenue Share by Application (2021-2032)
- Asia Neurorehabilitation Revenue by Country
- Asia Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
- Asia Neurorehabilitation Revenue by Country (2021-2026)
- Asia Neurorehabilitation Revenue by Country (2027-2032)
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America, Middle East and Africa
- SAMEA Neurorehabilitation Revenue (2021-2032)
- SAMEA Neurorehabilitation Revenue by Type (2021-2032)
- SAMEA Neurorehabilitation Revenue by Type (2021-2026)
- SAMEA Neurorehabilitation Revenue by Type (2027-2032)
- SAMEA Neurorehabilitation Revenue Share by Type (2021-2032)
- SAMEA Neurorehabilitation Revenue by Application (2021-2032)
- SAMEA Neurorehabilitation Revenue by Application (2021-2026)
- SAMEA Neurorehabilitation Revenue by Application (2027-2032)
- SAMEA Neurorehabilitation Revenue Share by Application (2021-2032)
- SAMEA Neurorehabilitation Revenue by Country
- SAMEA Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
- SAMEA Neurorehabilitation Revenue by Country (2021-2026)
- SAMEA Neurorehabilitation Revenue by Country (2027-2032)
- Brazil
- Argentina
- Chile
- Colombia
- Peru
- Saudi Arabia
- Israel
- UAE
- Turkey
- Iran
- Egypt
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
List of Tables
| Table 1 | :Global Neurorehabilitation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 |
| Table 2 | :Implantable Neurorehabilitation Systems Major Player |
| Table 3 | :Neurorobotic Systems Major Player |
| Table 4 | :Functional Electrical Stimulation and Neuroprosthetics Major Player |
| Table 5 | :Brain-computer Interfaces Major Player |
| Table 6 | :Non-invasive Stimulators Major Player |
| Table 7 | :Sensor-based Assessment and Digital Rehab Platforms Major Player |
| Table 8 | :Other Major Player |
| Table 9 | :Global Neurorehabilitation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 |
| Table 10 | :Hospitals Major Player |
| Table 11 | :Clinics Major Player |
| Table 12 | :Neurorehabilitation Industry Trends |
| Table 13 | :Neurorehabilitation Industry Drivers |
| Table 14 | :Neurorehabilitation Industry Opportunities and Challenges |
| Table 15 | :Neurorehabilitation Industry Restraints |
| Table 16 | :Global Neurorehabilitation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 |
| Table 17 | :Global Neurorehabilitation Market Size by Region (2021-2026) & (US$ Million) |
| Table 18 | :Global Neurorehabilitation Market Share by Region (2021-2026) |
| Table 19 | :Global Neurorehabilitation Market Size by Region (2027-2032) & (US$ Million) |
| Table 20 | :Global Neurorehabilitation Market Share by Region (2027-2032) |
| Table 21 | :Global Neurorehabilitation Revenue by Players (US$ Million) & (2021-2026) |
| Table 22 | :Global Neurorehabilitation Revenue Market Share by Players (2021-2026) |
| Table 23 | :Global Neurorehabilitation Key Players Ranking, 2024 VS 2025 VS 2026 |
| Table 24 | :Global Neurorehabilitation Key Players Headquarters & Area Served |
| Table 25 | :Global Neurorehabilitation Players, Product Type & Application |
| Table 26 | :Global Neurorehabilitation Players Establishment Date |
| Table 27 | :Global Players Market Concentration Ratio (CR5 and HHI) |
| Table 28 | :Global Neurorehabilitation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) |
| Table 29 | :Global Neurorehabilitation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) |
| Table 30 | :Global Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) |
| Table 31 | :Global Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) |
| Table 32 | :Global Neurorehabilitation Revenue Market Share by Type (2021-2026) |
| Table 33 | :Global Neurorehabilitation Revenue Market Share by Type (2027-2032) |
| Table 34 | :Global Neurorehabilitation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) |
| Table 35 | :Global Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) |
| Table 36 | :Global Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) |
| Table 37 | :Global Neurorehabilitation Revenue Market Share by Application (2021-2026) |
| Table 38 | :Global Neurorehabilitation Revenue Market Share by Application (2027-2032) |
| Table 39 | :Medtronic Company Information |
| Table 40 | :Medtronic Business Overview |
| Table 41 | :Medtronic Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 42 | :Medtronic Neurorehabilitation Product Portfolio |
| Table 43 | :Medtronic Recent Development |
| Table 44 | :Abbott Laboratories Company Information |
| Table 45 | :Abbott Laboratories Business Overview |
| Table 46 | :Abbott Laboratories Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 47 | :Abbott Laboratories Neurorehabilitation Product Portfolio |
| Table 48 | :Abbott Laboratories Recent Development |
| Table 49 | :Boston Scientific Company Information |
| Table 50 | :Boston Scientific Business Overview |
| Table 51 | :Boston Scientific Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 52 | :Boston Scientific Neurorehabilitation Product Portfolio |
| Table 53 | :Boston Scientific Recent Development |
| Table 54 | :Bioness Company Information |
| Table 55 | :Bioness Business Overview |
| Table 56 | :Bioness Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 57 | :Bioness Neurorehabilitation Product Portfolio |
| Table 58 | :Bioness Recent Development |
| Table 59 | :Hocoma AG Company Information |
| Table 60 | :Hocoma AG Business Overview |
| Table 61 | :Hocoma AG Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 62 | :Hocoma AG Neurorehabilitation Product Portfolio |
| Table 63 | :Hocoma AG Recent Development |
| Table 64 | :Neuronetics Company Information |
| Table 65 | :Neuronetics Business Overview |
| Table 66 | :Neuronetics Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 67 | :Neuronetics Neurorehabilitation Product Portfolio |
| Table 68 | :Neuronetics Recent Development |
| Table 69 | :Wuhan Yiruide Group Company Information |
| Table 70 | :Wuhan Yiruide Group Business Overview |
| Table 71 | :Wuhan Yiruide Group Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 72 | :Wuhan Yiruide Group Neurorehabilitation Product Portfolio |
| Table 73 | :Wuhan Yiruide Group Recent Development |
| Table 74 | :Magstim Company Information |
| Table 75 | :Magstim Business Overview |
| Table 76 | :Magstim Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 77 | :Magstim Neurorehabilitation Product Portfolio |
| Table 78 | :Magstim Recent Development |
| Table 79 | :Nanjing Vishee Medical Company Information |
| Table 80 | :Nanjing Vishee Medical Business Overview |
| Table 81 | :Nanjing Vishee Medical Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 82 | :Nanjing Vishee Medical Neurorehabilitation Product Portfolio |
| Table 83 | :Nanjing Vishee Medical Recent Development |
| Table 84 | :Ekso Bionics Company Information |
| Table 85 | :Ekso Bionics Business Overview |
| Table 86 | :Ekso Bionics Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) |
| Table 87 | :Ekso Bionics Neurorehabilitation Product Portfolio |
| Table 88 | :Ekso Bionics Recent Development |
| Table 89 | :Alter G Company Information |
| Table 90 | :Alter G Business Overview |
| Table 91 | :Alter G Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 92 | :Alter G Neurorehabilitation Product Portfolio |
| Table 93 | :Alter G Recent Development |
| Table 94 | :MagVenture Company Information |
| Table 95 | :MagVenture Business Overview |
| Table 96 | :MagVenture Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 97 | :MagVenture Neurorehabilitation Product Portfolio |
| Table 98 | :MagVenture Recent Development |
| Table 99 | :Tyromotion Company Information |
| Table 100 | :Tyromotion Business Overview |
| Table 101 | :Tyromotion Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 102 | :Tyromotion Neurorehabilitation Product Portfolio |
| Table 103 | :Tyromotion Recent Development |
| Table 104 | :Soterix Medical Company Information |
| Table 105 | :Soterix Medical Business Overview |
| Table 106 | :Soterix Medical Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 107 | :Soterix Medical Neurorehabilitation Product Portfolio |
| Table 108 | :Soterix Medical Recent Development |
| Table 109 | :Neuroelectrics Company Information |
| Table 110 | :Neuroelectrics Business Overview |
| Table 111 | :Neuroelectrics Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 112 | :Neuroelectrics Neurorehabilitation Product Portfolio |
| Table 113 | :Neuroelectrics Recent Development |
| Table 114 | :Bionik Laboratories Company Information |
| Table 115 | :Bionik Laboratories Business Overview |
| Table 116 | :Bionik Laboratories Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 117 | :Bionik Laboratories Neurorehabilitation Product Portfolio |
| Table 118 | :Bionik Laboratories Recent Development |
| Table 119 | :Helius Medical Company Information |
| Table 120 | :Helius Medical Business Overview |
| Table 121 | :Helius Medical Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 122 | :Helius Medical Neurorehabilitation Product Portfolio |
| Table 123 | :Helius Medical Recent Development |
| Table 124 | :LivaNova Company Information |
| Table 125 | :LivaNova Business Overview |
| Table 126 | :LivaNova Neurorehabilitation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) |
| Table 127 | :LivaNova Neurorehabilitation Product Portfolio |
| Table 128 | :LivaNova Recent Development |
| Table 129 | :North America Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) |
| Table 130 | :North America Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) |
| Table 131 | :North America Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) |
| Table 132 | :North America Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) |
| Table 133 | :North America Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) |
| Table 134 | :North America Neurorehabilitation Revenue by Country (2021-2026) & (US$ Million) |
| Table 135 | :North America Neurorehabilitation Revenue by Country (US$ Million) & (2027-2032) |
| Table 136 | :Europe Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) |
| Table 137 | :Europe Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) |
| Table 138 | :Europe Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) |
| Table 139 | :Europe Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) |
| Table 140 | :Europe Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) |
| Table 141 | :Europe Neurorehabilitation Revenue by Country (2021-2026) & (US$ Million) |
| Table 142 | :Europe Neurorehabilitation Revenue by Country (US$ Million) & (2027-2032) |
| Table 143 | :China Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) |
| Table 144 | :China Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) |
| Table 145 | :China Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) |
| Table 146 | :China Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) |
| Table 147 | :Asia Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) |
| Table 148 | :Asia Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) |
| Table 149 | :Asia Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) |
| Table 150 | :Asia Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) |
| Table 151 | :Asia Neurorehabilitation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) |
| Table 152 | :Asia Neurorehabilitation Revenue by Region (US$ Million) & (2021-2026) |
| Table 153 | :Asia Neurorehabilitation Revenue by Region (US$ Million) & (2027-2032) |
| Table 154 | :SAMEA Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) |
| Table 155 | :SAMEA Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) |
| Table 156 | :SAMEA Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) |
| Table 157 | :SAMEA Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) |
| Table 158 | :SAMEA Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) |
| Table 159 | :SAMEA Neurorehabilitation Revenue by Country (2021-2026) & (US$ Million) |
| Table 160 | :SAMEA Neurorehabilitation Revenue by Country (US$ Million) & (2027-2032) |
| Table 161 | :Research Programs/Design for This Report |
| Table 162 | :Authors List of This Report |
| Table 163 | :Secondary Sources |
| Table 164 | :Primary Sources |
List of Figures
| Figure 1 | :Neurorehabilitation Image |
| Figure 2 | :Global Neurorehabilitation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 |
| Figure 3 | :Global Neurorehabilitation Market Size Share 2021 VS 2025 VS 2032 |
| Figure 4 | :Implantable Neurorehabilitation Systems Image |
| Figure 5 | :Neurorobotic Systems Image |
| Figure 6 | :Functional Electrical Stimulation and Neuroprosthetics Image |
| Figure 7 | :Brain-computer Interfaces Image |
| Figure 8 | :Non-invasive Stimulators Image |
| Figure 9 | :Sensor-based Assessment and Digital Rehab Platforms Image |
| Figure 10 | :Other Image |
| Figure 11 | :Global Neurorehabilitation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 |
| Figure 12 | :Global Neurorehabilitation Market Size Share 2021 VS 2025 VS 2032 |
| Figure 13 | :Hospitals Image |
| Figure 14 | :Clinics Image |
| Figure 15 | :Global Neurorehabilitation Market Size (US$ Million) & (2021-2032) |
| Figure 16 | :Global Neurorehabilitation Market Size, (US$ Million), 2021 VS 2025 VS 2032 |
| Figure 17 | :Global Neurorehabilitation Market Share by Region: 2021 VS 2025 VS 2032 |
| Figure 18 | :Global Neurorehabilitation Players Revenue Share Top 10 and Top 5 in 2025 |
| Figure 19 | :Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 |
| Figure 20 | :Global Neurorehabilitation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) |
| Figure 21 | :Global Neurorehabilitation Revenue Market Share 2021 VS 2025 VS 2032 |
| Figure 22 | :Global Neurorehabilitation Revenue Market Share by Type (2021-2032) |
| Figure 23 | :Global Neurorehabilitation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) |
| Figure 24 | :Global Neurorehabilitation Revenue Market Share by Application (2021 VS 2025 VS 2032) |
| Figure 25 | :Global Neurorehabilitation Revenue Market Share by Application (2021-2032) |
| Figure 26 | :North America Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) |
| Figure 27 | :North America Neurorehabilitation Revenue Share by Type (2021-2032) |
| Figure 28 | :North America Neurorehabilitation Revenue Share by Application (2021-2032) |
| Figure 29 | :North America Neurorehabilitation Revenue Share by Country (2021-2032) |
| Figure 30 | :United States Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 31 | :Canada Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 32 | :Mexico Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 33 | :Europe Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) |
| Figure 34 | :Europe Neurorehabilitation Revenue Share by Type (2021-2032) |
| Figure 35 | :Europe Neurorehabilitation Revenue Share by Application (2021-2032) |
| Figure 36 | :Europe Neurorehabilitation Revenue Share by Country (2021-2032) |
| Figure 37 | :Germany Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 38 | :France Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 39 | :U.K. Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 40 | :Italy Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 41 | :Spain Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 42 | :Russia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 43 | :Netherlands Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 44 | :Nordic Countries Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 45 | :China Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) |
| Figure 46 | :China Neurorehabilitation Revenue Share by Type (2021-2032) |
| Figure 47 | :China Neurorehabilitation Revenue Share by Application (2021-2032) |
| Figure 48 | :Asia Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) |
| Figure 49 | :Asia Neurorehabilitation Revenue Share by Type (2021-2032) |
| Figure 50 | :Asia Neurorehabilitation Revenue Share by Application (2021-2032) |
| Figure 51 | :Asia Neurorehabilitation Revenue Share by Region (2021-2032) |
| Figure 52 | :Japan Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 53 | :South Korea Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 54 | :India Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 55 | :Australia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 56 | :Taiwan Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 57 | :Southeast Asia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 58 | :SAMEA Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) |
| Figure 59 | :SAMEA Neurorehabilitation Revenue Share by Type (2021-2032) |
| Figure 60 | :SAMEA Neurorehabilitation Revenue Share by Application (2021-2032) |
| Figure 61 | :SAMEA Neurorehabilitation Revenue Share by Country (2021-2032) |
| Figure 62 | :Brazil Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 63 | :Argentina Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 64 | :Chile Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 65 | :Colombia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 66 | :Peru Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 67 | :Saudi Arabia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 68 | :Israel Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 69 | :UAE Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 70 | :Turkey Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 71 | :Iran Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 72 | :Egypt Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) |
| Figure 73 | :Years Considered |
| Figure 74 | :Research Process |
| Figure 75 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Medical Care
Global Neurorehabilitation Market Analysis and Forecast 2026-2032
Pages: 207
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.